LV10387B - Process for producing of drugs and application thereof on medicinal purpose - Google Patents

Process for producing of drugs and application thereof on medicinal purpose Download PDF

Info

Publication number
LV10387B
LV10387B LVP-93-303A LV930303A LV10387B LV 10387 B LV10387 B LV 10387B LV 930303 A LV930303 A LV 930303A LV 10387 B LV10387 B LV 10387B
Authority
LV
Latvia
Prior art keywords
alkyl
hydrogen
der
formula
und
Prior art date
Application number
LVP-93-303A
Other languages
English (en)
Latvian (lv)
Other versions
LV10387A (lv
Inventor
Baader Ekkehard
Burghard Harald
Genzler-Pukall Volkmar
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of LV10387A publication Critical patent/LV10387A/xx
Publication of LV10387B publication Critical patent/LV10387B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/56—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having carbon atoms of carboxamide groups bound to carbon atoms of carboxyl groups, e.g. oxamides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
LVP-93-303A 1990-05-12 1993-05-07 Process for producing of drugs and application thereof on medicinal purpose LV10387B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4015255A DE4015255A1 (de) 1990-05-12 1990-05-12 Oxalyl-aminosaeurederivate, verfahren zu ihrer herstellung und ihrer verwendung als arzneimittel zur inhibierung der prolyl-hydroxylase

Publications (2)

Publication Number Publication Date
LV10387A LV10387A (lv) 1995-02-20
LV10387B true LV10387B (en) 1996-02-20

Family

ID=6406245

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-303A LV10387B (en) 1990-05-12 1993-05-07 Process for producing of drugs and application thereof on medicinal purpose

Country Status (28)

Country Link
US (1) US5204338A (ru)
EP (1) EP0457163B1 (ru)
JP (1) JP2504874B2 (ru)
KR (1) KR910019612A (ru)
CN (1) CN1032253C (ru)
AT (1) ATE108177T1 (ru)
AU (1) AU641760B2 (ru)
BR (1) BR9101927A (ru)
CA (1) CA2042282A1 (ru)
CZ (1) CZ279939B6 (ru)
DE (2) DE4015255A1 (ru)
DK (1) DK0457163T3 (ru)
EG (1) EG19762A (ru)
ES (1) ES2057655T3 (ru)
HR (1) HRP940695B1 (ru)
HU (1) HU217974B (ru)
IE (1) IE65298B1 (ru)
IL (1) IL98109A (ru)
LT (1) LT3953B (ru)
LV (1) LV10387B (ru)
MA (1) MA22152A1 (ru)
MX (1) MX25723A (ru)
MY (1) MY108608A (ru)
NZ (1) NZ238112A (ru)
PT (1) PT97642B (ru)
RU (1) RU2025123C1 (ru)
TW (1) TW225988B (ru)
ZA (1) ZA913538B (ru)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192773A (en) * 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
US5620971A (en) * 1991-05-09 1997-04-15 Vertex Pharmaceuticals Incorporated Biologically active acylated amino acid derivatives
DK0584223T3 (da) * 1991-05-09 2000-03-13 Vertex Pharma Hidtil ukendte immunsuppressive forbindelser
US5723459A (en) * 1991-05-09 1998-03-03 Vertex Pharmaceuticals Incorporated Biologically active acylated amino acid derivatives
DK0650961T3 (da) 1993-11-02 1997-09-15 Hoechst Ag Substituerede heterocykliske carboxylsyreamider, deres fremstilling og deres anvendelse som lægemidler.
ATE149485T1 (de) * 1993-11-02 1997-03-15 Hoechst Ag Substituierte heterocyclische carbonsäureamidester, ihre herstellung und ihre verwendung als arzneimittel
CA2138929A1 (en) * 1993-12-30 1995-07-01 Klaus Weidmann Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
US5543423A (en) * 1994-11-16 1996-08-06 Vertex Pharmaceuticals, Incorporated Amino acid derivatives with improved multi-drug resistance activity
US6046219A (en) * 1995-01-20 2000-04-04 Cornell Research Foundation, Inc. Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation
US5789426A (en) * 1995-01-20 1998-08-04 Cornell Research Foundation, Inc. Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US7056935B2 (en) 1995-06-07 2006-06-06 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
IL135495A (en) * 1995-09-28 2002-12-01 Hoechst Ag Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid
US5801197A (en) * 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5717092A (en) * 1996-03-29 1998-02-10 Vertex Pharmaceuticals Inc. Compounds with improved multi-drug resistance activity
US5786378A (en) * 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5801187A (en) * 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US6218424B1 (en) 1996-09-25 2001-04-17 Gpi Nil Holdings, Inc. Heterocyclic ketone and thioester compounds and uses
DE19650215A1 (de) * 1996-12-04 1998-06-10 Hoechst Ag 3-Hydroxypyridin-2-carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
US6271244B1 (en) 1998-06-03 2001-08-07 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses
US6274602B1 (en) 1998-06-03 2001-08-14 Gpi Nil Holdings, Inc. Heterocyclic thioester and ketone hair growth compositions and uses
US6187784B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Pipecolic acid derivative hair growth compositions and uses
US20010049381A1 (en) 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
US6187796B1 (en) 1998-06-03 2001-02-13 Gpi Nil Holdings, Inc. Sulfone hair growth compositions and uses
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
DE19746287A1 (de) * 1997-10-20 1999-04-22 Hoechst Marion Roussel De Gmbh Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
US6172087B1 (en) 1998-06-03 2001-01-09 Gpi Nil Holding, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
US6429215B1 (en) 1998-06-03 2002-08-06 Gpi Nil Holdings, Inc. N-oxide of heterocyclic ester, amide, thioester, or ketone hair growth compositions and uses
WO1999062487A1 (en) 1998-06-03 1999-12-09 Gpi Nil Holdings, Inc. Heterocyclic ester and amide hair growth compositions and uses
US6335348B1 (en) 1998-08-14 2002-01-01 Gpi Nil Holdings, Inc. Nitrogen-containing linear and azepinyl/ compositions and uses for vision and memory disorders
US7338976B1 (en) 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6384056B1 (en) 1998-08-14 2002-05-07 Gpi Nil Holdings, Inc. Heterocyclic thioesters or ketones for vision and memory disorders
US6333340B1 (en) 1998-08-14 2001-12-25 Gpi Nil Holdings, Inc. Small molecule sulfonamides for vision and memory disorders
US6506788B1 (en) 1998-08-14 2003-01-14 Gpi Nil Holdings, Inc. N-linked urea or carbamate of heterocyclic thioesters for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
DK2298301T3 (en) * 2001-12-06 2018-10-01 Fibrogen Inc MEDICINALS FOR TREATMENT OF ANEMIA ASSOCIATED WITH Kidney Disease
JPWO2006134963A1 (ja) * 2005-06-15 2009-01-08 日本臓器製薬株式会社 オキサルル酸誘導体を含有する線維性疾患用剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1645987A1 (de) * 1966-08-08 1971-01-21 Ajinomoto Kk Oxalzolderivate und Verfahren zu deren Herstellung
FR1533817A (fr) * 1966-08-08 1968-07-19 Ajinomoto Kk Dérivés d'oxazole et leur procédé de préparation
US3646061A (en) * 1968-06-10 1972-02-29 Ajinomoto Kk Method of preparing n-alkoxalyl and n-formyl derivatives of alpha-amino acid esters

Also Published As

Publication number Publication date
DK0457163T3 (da) 1994-10-17
IE911608A1 (en) 1991-11-20
RU2025123C1 (ru) 1994-12-30
EP0457163B1 (de) 1994-07-06
ES2057655T3 (es) 1994-10-16
IL98109A0 (en) 1992-06-21
IE65298B1 (en) 1995-10-18
ATE108177T1 (de) 1994-07-15
CN1056683A (zh) 1991-12-04
HRP940695A2 (en) 1997-02-28
LT3953B (en) 1996-05-27
BR9101927A (pt) 1991-12-17
DE4015255A1 (de) 1991-11-14
HU217974B (hu) 2000-05-28
PT97642B (pt) 1998-08-31
LTIP1460A (en) 1995-05-25
US5204338A (en) 1993-04-20
CA2042282A1 (en) 1991-11-13
NZ238112A (en) 1993-12-23
EG19762A (en) 1996-01-31
CN1032253C (zh) 1996-07-10
MY108608A (en) 1996-10-31
TW225988B (ru) 1994-07-01
ZA913538B (en) 1992-02-26
EP0457163A1 (de) 1991-11-21
LV10387A (lv) 1995-02-20
AU641760B2 (en) 1993-09-30
MA22152A1 (fr) 1991-12-31
MX25723A (es) 1993-04-01
AU7622191A (en) 1991-11-14
HU157291D0 (en) 1991-11-28
JPH04226913A (ja) 1992-08-17
HUT57581A (en) 1991-12-30
CZ279939B6 (cs) 1995-09-13
HRP940695B1 (en) 1999-04-30
JP2504874B2 (ja) 1996-06-05
KR910019612A (ko) 1991-12-19
DE59102102D1 (de) 1994-08-11
IL98109A (en) 1995-07-31
PT97642A (pt) 1992-02-28

Similar Documents

Publication Publication Date Title
LV10387B (en) Process for producing of drugs and application thereof on medicinal purpose
US4305958A (en) Cysteine derivatives
EP0119161B1 (de) Gewisse Benzazocinon- und Benzazoninon-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
DE3143219A1 (de) Kristalline 1,1-dioxopenicillanoyloxymethyl-6-(d-(alpha)-amino-(alpha)-phenylacetamido)-penicillanat-p-toluol-sulfonat-hydrate, verfahren zu deren herstellung und diese enthaltende arzneimittel
JPH08510479A (ja) 眼の炎症障害を処置するための３‐ベンゾイルフェニル酢酸誘導体を含む局所的に投与可能な組成物
DE3443231A1 (de) Polysubstituierte naphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung auf dem pharmazeutischen und kosmetischen gebiet
CA1294971C (fr) Derives benzofuranniques, leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant
US4839387A (en) Derivative of thiazolidine-4-carboxylic acid, its preparation and pharmaceutical compositions containing it
FR2713637A1 (fr) Nouveaux composés bi-aromatiques dérivés d'amide, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
DE2923009A1 (de) Mittel zur prophylaxe und behandlung der fibrose
CA1340005C (en) Pharmaceutical composition for the treatment of psoriasis
DE3138092C2 (de) Verwendung von 3-Amino-2-hydroxy-4-phenylbuttersäure und einigen ihrer verwandten Verbindungen
US5350768A (en) Derivatives of cysteine
DE2727047A1 (de) Indol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
FR2730995A1 (fr) Composes bi-aromatiques derives d'amide, compositions pharmaceutiques et cosmetiques les contenant et utilisations
CZ279343B6 (cs) Nové kyseliny 3,3` -dithiobis(propionové) a jejich estery
DE3126606C2 (de) (2S,3R)-3-Amino-2-hydroxy-4-phenylbutansäure-amide und -peptide sowie diese enthaltende Arzneimittel
PT1043332E (pt) Dipeptídeos contendo ciclopentano-beta-aminoácidos
AU615244B2 (en) New derivatives of cysteine, processes for their preparation and their use
DE2601820A1 (de) Kathepsin d-inhibitoren
DE1770915A1 (de) Neue Isoindolino-sulfonylharnstoffderivate und Verfahren zu ihrer Herstellung
JPS5531089A (en) Furil substituted polyene compound
DE69214280T2 (de) Thiocarbamat-sulfo-oxid enthaltende zubereitung zur abschreckung gegen ethanoleinnahme
EP0564499A1 (en) Novel amines, process for producing them and medicaments containing said compounds.
DE2029823C3 (de) L-alpha-Hydrazino-a-methyl-beta-(3,4dihydroxyphenyl)-propionsäure mit einem Gehalt an dem D-Isomeren von weniger als 10%, deren pharmakologisch nicht toxischen Salze und deren Alkylester mit 1 bis 5 Kohlenstoffatomen